These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34355692)

  • 1.
    Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
    Elife; 2021 Aug; 10():. PubMed ID: 34355692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.
    Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
    PLoS One; 2024; 19(5):e0301328. PubMed ID: 38713657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.
    Ree R; Geithus AS; Tørring PM; Sørensen KP; Damkjær M; ; Lynch SA; Arnesen T
    BMC Med Genet; 2019 Jun; 20(1):101. PubMed ID: 31174490
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    McTiernan N; Darbakk C; Ree R; Arnesen T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.
    Van Damme P; Støve SI; Glomnes N; Gevaert K; Arnesen T
    Mol Cell Proteomics; 2014 Aug; 13(8):2031-41. PubMed ID: 24408909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.
    Lee MN; Kweon HY; Oh GT
    Exp Mol Med; 2018 Jul; 50(7):1-11. PubMed ID: 30054454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the Phenotype Associated with NAA10-Related N-Terminal Acetylation Deficiency.
    Saunier C; Støve SI; Popp B; Gérard B; Blenski M; AhMew N; de Bie C; Goldenberg P; Isidor B; Keren B; Leheup B; Lampert L; Mignot C; Tezcan K; Mancini GM; Nava C; Wasserstein M; Bruel AL; Thevenon J; Masurel A; Duffourd Y; Kuentz P; Huet F; Rivière JB; van Slegtenhorst M; Faivre L; Piton A; Reis A; Arnesen T; Thauvin-Robinet C; Zweier C
    Hum Mutat; 2016 Aug; 37(8):755-64. PubMed ID: 27094817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating possible maternal effect lethality and genetic background effects in
    Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
    bioRxiv; 2024 Jan; ():. PubMed ID: 37163119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae.
    Varland S; Arnesen T
    BMC Res Notes; 2018 Jun; 11(1):404. PubMed ID: 29929531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy.
    McTiernan N; Gill H; Prada CE; Pachajoa H; Lores J; ; Arnesen T
    Eur J Hum Genet; 2021 Feb; 29(2):280-288. PubMed ID: 32973342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
    Magin RS; March ZM; Marmorstein R
    J Biol Chem; 2016 Mar; 291(10):5270-7. PubMed ID: 26755727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy.
    Støve SI; Blenski M; Stray-Pedersen A; Wierenga KJ; Jhangiani SN; Akdemir ZC; Crawford D; McTiernan N; Myklebust LM; Purcarin G; McNall-Knapp R; Wadley A; Belmont JW; Kim JJ; Lupski JR; Arnesen T
    Eur J Hum Genet; 2018 Sep; 26(9):1294-1305. PubMed ID: 29748569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
    Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
    Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.
    Lyon GJ; Vedaie M; Beisheim T; Park A; Marchi E; Gottlieb L; Hsieh TC; Klinkhammer H; Sandomirsky K; Cheng H; Starr LJ; Preddy I; Tseng M; Li Q; Hu Y; Wang K; Carvalho A; Martinez F; Caro-Llopis A; Gavin M; Amble K; Krawitz P; Marmorstein R; Herr-Israel E
    Eur J Hum Genet; 2023 Jul; 31(7):824-833. PubMed ID: 37130971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naa10 in development and disease.
    Myklebust LM; Støve SI; Arnesen T
    Oncotarget; 2015 Oct; 6(33):34041-2. PubMed ID: 26431279
    [No Abstract]   [Full Text] [Related]  

  • 18. NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report.
    McTiernan N; Støve SI; Aukrust I; Mårli MT; Myklebust LM; Houge G; Arnesen T
    BMC Med Genet; 2018 Mar; 19(1):47. PubMed ID: 29558889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxylation of the Acetyltransferase NAA10 Trp38 Is Not an Enzyme-Switch in Human Cells.
    Ree R; Krogstad K; McTiernan N; Jakobsson ME; Arnesen T
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal acetyltransferase Naa10 is essential for zebrafish development.
    Ree R; Myklebust LM; Thiel P; Foyn H; Fladmark KE; Arnesen T
    Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26251455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.